rs2069414

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001798.5(CDK2):​c.*290C>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0473 in 345,882 control chromosomes in the GnomAD database, including 504 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.041 ( 185 hom., cov: 32)
Exomes 𝑓: 0.053 ( 319 hom. )

Consequence

CDK2
NM_001798.5 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.85

Publications

11 publications found
Variant links:
Genes affected
CDK2 (HGNC:1771): (cyclin dependent kinase 2) This gene encodes a member of a family of serine/threonine protein kinases that participate in cell cycle regulation. The encoded protein is the catalytic subunit of the cyclin-dependent protein kinase complex, which regulates progression through the cell cycle. Activity of this protein is especially critical during the G1 to S phase transition. This protein associates with and regulated by other subunits of the complex including cyclin A or E, CDK inhibitor p21Cip1 (CDKN1A), and p27Kip1 (CDKN1B). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]
PMEL (HGNC:10880): (premelanosome protein) This gene encodes a melanocyte-specific type I transmembrane glycoprotein. The encoded protein is enriched in melanosomes, which are the melanin-producing organelles in melanocytes, and plays an essential role in the structural organization of premelanosomes. This protein is involved in generating internal matrix fibers that define the transition from Stage I to Stage II melanosomes. This protein undergoes a complex pattern of prosttranslational processing and modification that is essential to the proper functioning of the protein. A secreted form of this protein that is released by proteolytic ectodomain shedding may be used as a melanoma-specific serum marker. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.063 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDK2NM_001798.5 linkc.*290C>A 3_prime_UTR_variant Exon 7 of 7 ENST00000266970.9 NP_001789.2
CDK2NM_052827.4 linkc.*290C>A 3_prime_UTR_variant Exon 6 of 6 NP_439892.2
CDK2NM_001290230.2 linkc.*290C>A 3_prime_UTR_variant Exon 5 of 5 NP_001277159.1
CDK2XM_011537732.2 linkc.*290C>A 3_prime_UTR_variant Exon 8 of 8 XP_011536034.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDK2ENST00000266970.9 linkc.*290C>A 3_prime_UTR_variant Exon 7 of 7 1 NM_001798.5 ENSP00000266970.4

Frequencies

GnomAD3 genomes
AF:
0.0406
AC:
6168
AN:
152088
Hom.:
185
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0113
Gnomad AMI
AF:
0.0614
Gnomad AMR
AF:
0.0285
Gnomad ASJ
AF:
0.0135
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.0350
Gnomad FIN
AF:
0.0488
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0646
Gnomad OTH
AF:
0.0374
GnomAD4 exome
AF:
0.0526
AC:
10195
AN:
193676
Hom.:
319
Cov.:
0
AF XY:
0.0526
AC XY:
5235
AN XY:
99556
show subpopulations
African (AFR)
AF:
0.0156
AC:
84
AN:
5390
American (AMR)
AF:
0.0251
AC:
186
AN:
7422
Ashkenazi Jewish (ASJ)
AF:
0.0168
AC:
116
AN:
6890
East Asian (EAS)
AF:
0.000143
AC:
2
AN:
14010
South Asian (SAS)
AF:
0.0371
AC:
432
AN:
11636
European-Finnish (FIN)
AF:
0.0550
AC:
697
AN:
12676
Middle Eastern (MID)
AF:
0.0387
AC:
38
AN:
982
European-Non Finnish (NFE)
AF:
0.0660
AC:
8062
AN:
122124
Other (OTH)
AF:
0.0461
AC:
578
AN:
12546
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
450
901
1351
1802
2252
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0405
AC:
6170
AN:
152206
Hom.:
185
Cov.:
32
AF XY:
0.0396
AC XY:
2945
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.0112
AC:
467
AN:
41536
American (AMR)
AF:
0.0285
AC:
435
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0135
AC:
47
AN:
3470
East Asian (EAS)
AF:
0.000579
AC:
3
AN:
5182
South Asian (SAS)
AF:
0.0353
AC:
170
AN:
4822
European-Finnish (FIN)
AF:
0.0488
AC:
517
AN:
10598
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.0646
AC:
4392
AN:
67996
Other (OTH)
AF:
0.0374
AC:
79
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
306
613
919
1226
1532
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0516
Hom.:
512
Bravo
AF:
0.0377
Asia WGS
AF:
0.0200
AC:
70
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.20
DANN
Benign
0.64
PhyloP100
-1.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2069414; hg19: chr12-56365699; API